Plínio Targa is the CEO of brain4care, a Brazilian deeptech company globally recognized for introducing a new vital sign to humanity.
The company’s AI-based technology unlocks this neurological vital sign by non-invasively monitoring intracranial pressure and compliance, enabling timely action to prevent irreversible brain damage.
Designed for population-level care, it is ubiquitous, affordable, and addresses a critical gap: the brain remains the least and most delayed monitored organ, even though time is brain.
brain4care’s non-invasive technology enhances the quality of care in conditions such as stroke, dementia, hydrocephalus, and trauma, as well as in general neurological disorder screening.
Plínio's leadership bridges science, innovation, and healthcare sustainability. His career spans academia (USP, FIA, FDC) and global companies (BAT, SAP, i2, EY, Axia), driving transformation across sectors.
